76 related articles for article (PubMed ID: 38629068)
21. HDAC1 mediates epithelial-mesenchymal transition and promotes cancer cell invasion in glioblastoma.
Cheng Z; Li S; Yuan J; Li Y; Cheng S; Huang S; Dong J
Pathol Res Pract; 2023 Jun; 246():154481. PubMed ID: 37121053
[TBL] [Abstract][Full Text] [Related]
22. CDC14B is a favorable biomarker for recurrence and prognosis of GBM.
Zhu C; Zhao Y; Zheng W
Clin Neurol Neurosurg; 2023 Apr; 227():107665. PubMed ID: 36898299
[TBL] [Abstract][Full Text] [Related]
23. Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma.
Huang K; Xu H; Han L; Xu R; Xu Z; Xie Y
Front Mol Biosci; 2022; 9():1054614. PubMed ID: 36699699
[No Abstract] [Full Text] [Related]
24. Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma.
Du R; Wang C; Liu J; Wang K; Dai L; Shen W
BMC Cancer; 2023 Jan; 23(1):52. PubMed ID: 36647029
[TBL] [Abstract][Full Text] [Related]
25. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
[TBL] [Abstract][Full Text] [Related]
26. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.
Wang F; Zhao F; Zhang L; Xiong L; Mao Q; Liu Y; Qiu X; Wang X; Shui L; Chen X; Ren K; Shui P; Zhang Q; Deng Y; Li W; Xie X; Wu D; Li T; Lang J; Liu L; Chen H; Xu J; Bai S; Li Z; Yue Q; Chen N; Zhou B; Yi C; Wei Y; Fu Y; Luo Y; Gou Q; Liu L; Liu Y; Kang J; Wang J; Jing D; Zhang F; Yang X; Li X; Jiang T; Zhang Z; Zhou Y; Yi J
Mol Cancer; 2022 Jul; 21(1):153. PubMed ID: 35879762
[TBL] [Abstract][Full Text] [Related]
27. PKM2 regulates cigarette smoke-induced airway inflammation and epithelial-to-mesenchymal transition via modulating PINK1/Parkin-mediated mitophagy.
Li D; Shen C; Liu L; Hu J; Qin J; Dai L; Gao L; Cheng M; Wang D; Bao R; Wang B
Toxicology; 2022 Jul; 477():153251. PubMed ID: 35787437
[TBL] [Abstract][Full Text] [Related]
28. Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages.
Liu Y; Yao R; Shi Y; Liu Y; Liu H; Liu J; Guan Y; Yao Y; Chen L
Front Immunol; 2022; 13():845223. PubMed ID: 35350788
[TBL] [Abstract][Full Text] [Related]
29. PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition.
Yang Y; Ren P; Liu X; Sun X; Zhang C; Du X; Xing B
J Exp Clin Cancer Res; 2022 Mar; 41(1):101. PubMed ID: 35292107
[TBL] [Abstract][Full Text] [Related]
30. Glioma targeted therapy: insight into future of molecular approaches.
Yang K; Wu Z; Zhang H; Zhang N; Wu W; Wang Z; Dai Z; Zhang X; Zhang L; Peng Y; Ye W; Zeng W; Liu Z; Cheng Q
Mol Cancer; 2022 Feb; 21(1):39. PubMed ID: 35135556
[TBL] [Abstract][Full Text] [Related]
31. Predicting the prognosis of glioma by pyroptosis-related signature.
Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F
J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches.
Mohiuddin E; Wakimoto H
Am J Cancer Res; 2021; 11(8):3742-3754. PubMed ID: 34522446
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA circMMP1 Contributes to the Progression of Glioma Through Regulating TGIF2 Expression by Sponging miR-195-5p.
Zhang K; Wang Q; Zhao D; Liu Z
Biochem Genet; 2022 Apr; 60(2):770-789. PubMed ID: 34471941
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-
Pan Y; Wang J; He L; Zhang F
J Immunol Res; 2021; 2021():6890423. PubMed ID: 33977112
[TBL] [Abstract][Full Text] [Related]
35. Ion Channels as Therapeutic Targets in High Grade Gliomas.
Griffin M; Khan R; Basu S; Smith S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096667
[TBL] [Abstract][Full Text] [Related]
36. Editorial: Follicular Helper T Cells in Immunity and Autoimmunity.
Cicalese MP; Salek-Ardakani S; Fousteri G
Front Immunol; 2020; 11():1042. PubMed ID: 32670272
[No Abstract] [Full Text] [Related]
37. TGIF2 promotes cervical cancer metastasis by negatively regulating FCMR.
Jiang J; Wu RH; Zhou HL; Li ZM; Kou D; Deng Z; Dong M; Chen LH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5953-5962. PubMed ID: 32572908
[TBL] [Abstract][Full Text] [Related]
38. Sevoflurane impedes the progression of glioma through modulating the circular RNA has_circ_0012129/miR-761/TGIF2 axis.
Xu W; Xue R; Xia R; Liu WW; Zheng JW; Tang L; Kang LY; Wang W; Wei WT
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5534-5548. PubMed ID: 32495888
[TBL] [Abstract][Full Text] [Related]
39. STAT Signaling in Glioma Cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
[TBL] [Abstract][Full Text] [Related]
40. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
